The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) Pilot
Condition(s):Age Related Macular DegenerationLast Updated:April 7, 2014Completed
Hide Studies Not Open or Pending
Condition(s):Age Related Macular DegenerationLast Updated:April 7, 2014Completed
Condition(s):Macular Edema; Retinal Vein OcclusionLast Updated:April 23, 2021Terminated
Condition(s):Retinal Vein Occlusion; Macular EdemaLast Updated:April 18, 2019Completed
Condition(s):Ophthalmology; Macular Edema; Macular DegenerationLast Updated:October 28, 2015Completed
Condition(s):Wet Macular DegenerationLast Updated:August 10, 2022Withdrawn
Condition(s):Macular DegenerationLast Updated:December 12, 2014Completed
Condition(s):Diabetic Macular EdemaLast Updated:February 19, 2019Completed
Condition(s):Age-related Macular DegenerationLast Updated:February 21, 2024Completed
Condition(s):Wet Age-related Macular Degeneration; Age-related Macular Degeneration; AMD; Wet AMD; Macular DegenerationLast Updated:December 30, 2011Withdrawn
Condition(s):Wet Macular DegenerationLast Updated:March 28, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.